Vanderbilt-Ingram Cancer Center holds the National Cancer Institute’s comprehensive cancer center designation, the agency’s highest ranking, and is the only such designated center in Tennessee that treats both adults and children. The center is a member of the National Comprehensive Cancer Network, an alliance of 32 of the world’s leading cancer centers, and serves as a lead academic participating site within the NCI’s National Clinical Trials Network, the world’s largest oncology clinical trials network. Vanderbilt-Ingram started “My Cancer Genome,” an international resource that helps physicians match specific genetic tumor mutations to available treatments. Its patient and family-centered care programs, based within the Vanderbilt Clinic’s Henry-Joyce Clinic, include a patient and family resource center, a patient advocacy program, the “Young Adults With Cancer Initiative,” an e-advisory council, and research advocacy and volunteering opportunities. In March 2026, Vanderbilt Health established a partnership with Bertis to integrate molecular AI capabilities with deep proteomics and computational spatial analysis, initially focusing on HER2-low tumors. Vanderbilt Health has also announced plans to pilot an innovation clinic that uses AI tools and a virtual patient guide, “Vivien,” to streamline outpatient care and expand community service capacity.
